Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
lump on the injection site; pain in injection site; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of injection site lump in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On 02-JAN-2025, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site lump (Verbatim: lump on the injection site) and injection site pain (Verbatim: pain in injection site). The outcome of the injection site lump and injection site pain were unknown. It was unknown if the reporter considered the injection site lump and injection site pain to be related to Shingrix. It was unknown if the company considered the injection site lump and injection site pain to be related to Shingrix. Additional Information: GSK Receipt Date : 13-MAR-2025 A patient had this vaccine last January twenty-twenty five, patient complained about a lump on the injection site and pain in injection site. The reporter questioned how much was this gonna last.